Sir, The emergence and rapid dissemination of Gram-negative pathogens carrying the plasmid-mediated colistin resistance mcr-1 gene have become a global threat to public health.
Sir, The emergence and rapid dissemination of Gram-negative pathogens carrying the plasmid-mediated colistin resistance mcr-1 gene have become a global threat to public health. 1 It is worrisome that the reservoirs for such organisms are increasing, not only in livestock, but also in wild animals and the environment. [2] [3] [4] In this regard, two recent reports published in JAC have described the presence of mcr-1-positive Escherichia coli in faecal samples of healthy wild birds (i.e. European herring gulls and kelp gulls). 3, 4 In this study, we report for the first known time the occurrence of E. coli carrying mcr-1 and bla CTX-M -type genes in infected migratory Magellanic penguins (Spheniscus magellanicus) suffering from bumblefoot (pododermatitis), highlighting a possible source of transmission of these organisms.
Magellanic penguins are seabirds that live exclusively in the Southern Hemisphere (Argentina, Chile and Falkland/Malvinas Islands). 5 Brazil is on the migration route of this species and every year a large number of these birds arrive on beaches of the south and southeast coast, 5 where animals are kept in rehabilitation centres. Between 2006 and 2014, 261 penguins were admitted to a rehabilitation centre on the southeast coast of Brazil (23 59 0 10.7 00 S, 46 18 0 30.1 00 W). About 70% did not survive due to malnutrition and weakness developed during the migration period. In 2013, 24 animals succumbed to pododermatitis, which was associated with underlying infection of the footpad. 6 Samples collected from infected footpads of 13 animals were positive for E. coli.
As part of an antimicrobial resistance surveillance study, we have investigated these E. coli strains for transferable colistin resistance and production of ESBL, 7 leading to the identification of three ESBL-producing E. coli strains (ICBEC7P, ICBEC11P and ICBEC12P), which exhibited an MDR profile to ampicillin, ceftiofur, ceftazidime (8 mg/L), cefotaxime (.32 mg/L), cefepime, aztreonam, amikacin, gentamicin (32 mg/L), sulfamethoxazole/ trimethoprim, enrofloxacin, ciprofloxacin (.32 mg/L) and tetracycline (64 mg/L), as determined by disc diffusion or Etest methods. 7 ESBL production was confirmed by using a double-disc synergy test (DDST), and PCR screening and sequencing revealed bla CTX-M-1 in ICBEC7P and ICBEC11P, and bla CTX-M-2 in ICBEC12P. Although all isolates remained susceptible to ertapenem (0.016 mg/L), imipenem, meropenem and cefoxitin (1 mg/L), the E. coli strain ICBEC7P showed additional resistance to colistin (8 mg/L), 8 due to the presence of the mcr-1 gene.
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The total genomic DNA of E. coli ICBEC7P was used to construct a paired-end library, which was sequenced using the MiSeq platform (Illumina). Genome assembly was carried out using SPAdes v3.9.0 and contigs were annotated using Prokka (www.github. com/tseemann/prokka). The 15.5 kbp contig containing the mcr-1 gene was found to bear an IncX4 replicon signature, as determined by the PlasmidFinder database (https://cge.cbs.dtu.dk/ser vices/PlasmidFinder/). Another 17.5 kbp contig was found to host a hit showing .99% identity to another IncX4 plasmid harbouring mcr-1, which we had sequenced using mate-pair reads (GenBank accession number CP015977). These two contigs were then concatenated with a gap, and the gap was closed and the plasmid circularized using the paired-end reads for ICBEC7P with GapFiller (www.baseclear.com/genomics/bioinformatics/basetools/ gapfiller). The complete circularized sequence of pICBEC7Pmcr was deposited in GenBank under accession number CP017246. Serotype, MLST ST, plasmid replicons, antimicrobial resistance genes and virulence genes for E. coli ICBEC7P were identified using the SerotypeFinder 1.1, MLST 1.8, PlasmidFinder 1.3, ResFinder 2.1 and VirulenceFinder 1.5 databases, respectively, available from the Center for Genomic Epidemiology (http://genomicepidemiology.org/).
The WGS analysis showed that E. coli ICBEC7P belonged to serotype ONT:H32 and MLST ST10. ST10 has been globally reported from livestock, food, human and environmental samples, being associ-ated with the production of CTX-M-type ESBLs and, more recently, the MCR-1 enzyme, supporting a great versatility for adaptation to different hosts. 9, 10 On the other hand, presence of the gad (glutamate decarboxylase) gene found in ICBEC7P can be associated with the low-virulence phylogenetic group A. E. coli ICBEC7P harboured IncFIB, IncN, IncHI2, IncHI2A, IncI1 and IncX4 plasmids. The plasmid bearing the bla CTX-M-1 gene (pICBEC7Pctx) was successfully transferred to the E. coli C600 strain by the broth mating method, and belonged to the IncFIB incompatibility group according to PCR-based replicon typing. 11 Transconjugants were selected on MacConkey agar plates containing streptomycin (200 mg/L) and ceftriaxone (2 mg/L). The 33.3 kb IncX4 plasmid carrying mcr-1 (pICBEC7Pmcr) displayed 95.2% nucleotide identity to a plasmid originating from a human patient in Brazil (pICBEC72Hmcr, GenBank accession number CP015977). 12 The only difference between the two plasmids was the truncation of mobA due to the insertion of IS1294 in pICBEC7Pmcr. This mutation may explain why the attempts to mobilize mcr-1 from E. coli ICBEC7P by in vitro conjugation were unsuccessful. Non-conjugative plasmids are common in members of the Enterobacteriaceae family, and probably rely largely on vertical transmission to be maintained in bacterial populations, 13 where they contribute to the persistence of resistance genes among clonal lineages.
The complete sequence of pICBEC7Pmcr reinforces the ubiquity of this IncX4 plasmid, which carries mcr-1, and sheds light on the role of this incompatibility group in the global spread of colistin resistance, 12, 14 even to wildlife. On the other hand, since E. coli is a potential zoonotic pathogen, a meticulous microbiological and epidemiological investigation of strains of this sort must be performed, in order to identify reservoirs and potential transmission routes.
